Personalized Medical Care & Dedicated International Patient Concierge
Press Release
Immunomodulatory effects of intraoperative dexmedetomidine on T helper 1, T helper 2, T helper 17
Prospective randomized double-blind clinical study co-authored by Dr. Hyo Jo Han on intraoperative dexmedetomidine and T-helper cytokine balance.
Schedule a ConsultationImmunomodulatory Effects of Intraoperative Dexmedetomidine on T Helper 1, T Helper 2, T Helper 17 and Regulatory T Cells Cytokine Levels
Authors: Jae-Myeong Lee, Hyo-Jo Han, Won-Kyu Choi, Subin Yoo, Soojin Baek, and Jaemin Lee
Abstract
Background: The ratio of T helper 1 (Th1) to T helper 2 (Th2) as well as T helper 17 (Th17) to regulatory T cells (Treg) represents the state and direction of immune response. This prospective, randomised, double-blind, dose-response clinical study investigated the effect of different doses of intraoperative dexmedetomidine on the expression of Th1, Th2, Th17 and Treg cytokines and their ratios in seventy-five patients undergoing laparoscopic cholecystectomy.
Clinical Relevance
Co-authored by Dr. Hyo Jo Han, this randomized clinical trial supports evidence-based perioperative immune modulation and pain medicine protocols at St. Mary's Wellness & Pain Medicine Clinic.